Journal
CANCERS
Volume 13, Issue 17, Pages -Publisher
MDPI
DOI: 10.3390/cancers13174497
Keywords
nanoparticles; nanocomposites; X-ray fluorescence microscopy (XFM); X-ray fluorescence (XRF) tomography; cell cycle; BIRC5
Categories
Funding
- NIH [CA107467, EB002100, GM104530, U54 CA151880, U54CA119341]
- DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]
- SHyNE Resource (NSF) [ECCS-2025633]
- IIN
- Northwestern's MRSEC program (NSF) [DMR-1720139]
- Northwestern University Pathology Core Facility
- Cancer Center Support Grant (NCI) [CA060553]
Ask authors/readers for more resources
Metal-oxide nanomaterials can enter cells and interact with cellular structures and molecules due to their physical-chemical properties. Imaging techniques like X-ray fluorescence microscopy help study these interactions, leading to the development of safer and more predictable nanoparticle-based therapies.
Simple Summary Metal-oxide nanomaterials enter cancer and normal cells even when not specifically targeted, and often interact with specific cellular structures and biological molecules solely due to their innate physical-chemical properties. This raises concerns for the use of nanoparticles, which can be alleviated only with rigorous studies of nanoparticle-cell interactions, studies independent of post-interaction labeling of nanomaterials. X-ray fluorescence microscopy is an imaging technique that quantifies and maps all chemical elements from the periodic table solely based on their native fluorescence excited by the incoming X-ray. We used two different instruments to interrogate the same sample in 3D at two different resolutions and determine heterogeneity of cell-to-cell interactions with nanomaterials, as well as subcellular nanoparticle distribution. This is the first example of multi-scale 3D X-ray fluorescence imaging. This work begins a new era of study on how nanoparticle-based therapies can be developed to be more predictable and safer for use. Research in cancer nanotechnology is entering its third decade, and the need to study interactions between nanomaterials and cells remains urgent. Heterogeneity of nanoparticle uptake by different cells and subcellular compartments represent the greatest obstacles to a full understanding of the entire spectrum of nanomaterials' effects. In this work, we used flow cytometry to evaluate changes in cell cycle associated with non-targeted nanocomposite uptake by individual cells and cell populations. Analogous single cell and cell population changes in nanocomposite uptake were explored by X-ray fluorescence microscopy (XFM). Very few nanoparticles are visible by optical imaging without labeling, but labeling increases nanoparticle complexity and the risk of modified cellular uptake. XFM can be used to evaluate heterogeneity of nanocomposite uptake by directly imaging the metal atoms present in the metal-oxide nanocomposites under investigation. While XFM mapping has been performed iteratively in 2D with the same sample at different resolutions, this study is the first example of serial tomographic imaging at two different resolutions. A cluster of cells exposed to non-targeted nanocomposites was imaged with a micron-sized beam in 3D. Next, the sample was sectioned for immunohistochemistry as well as a high resolution zoomed in X-ray fluorescence (XRF) tomography with 80 nm beam spot size. Multiscale XRF tomography will revolutionize our ability to explore cell-to-cell differences in nanomaterial uptake.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available